Latest / Raleigh News Today | 2 Min News | The Daily News Now!
Moderna’s Big Pivot and Why Cramer’s Back | Raleigh News
Moderna’s stock just had a massive turnaround after Jim Cramer flipped his stance—once dismissing it as past its prime, he now calls it investable again, fueled by breakthroughs in cancer vaccines, rare disease treatments, and a potential mRNA flu shot poised for FDA approval. The company’s Science Day revealed a 10-year roadmap with promising trial data, sending shares up 150% this year. But with a big Q1 loss and flu revenue delayed until 2027, Cramer urges patience—don’t chase the rally, wait for a dip. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.